References
Balkwill FR, Burke F: The cytokine network. Immunol Today 1989;10:299–304.
Elson CO, Kagnoff MF, Fiocchi C, Befus AD, Targan S: Intestinal immunity and inflammation: Recent progress. Gastroenterology 1986;91:746–768.
Miura M, Hiwatashi N: Cytokine production in inflammatory bowel disease. J Clin Lab Immunol 1985;18:81–86.
Satsangi J, Wolstencroft RA, Cason J, Ainly CC, Dumonde DC, Thompson RPH: Interleukin 1 in Crohn's disease. Clin Exp Immunol 1987;67:594–605.
Mahida YR, Wu K, Jewell DP: Enhanced production of interleukin 1-β by mononuclear cells isolated from mucosa with active ulcerative colitis and Crohns' disease. Gut 1989;30:835–838.
Ligumsky M, Simon PL, Karmeli F, Rachmilewitz D: Role of interleukin 1 in inflammatory bowel disease-enhanced production during active disease. Gut 1990;31:686–689.
Matsumoto T, Kitano A, Nakamura S, Oshitani N, Obata A, Hiki M, Hashimura H, Okawa K, Kobayashi K, Nagura H: Possible role of vascular endothelial cells in immune responses in colonic mucosa examined immunohistochemically in subjects with and without ulcerative colitis. Clin Exp Immunol 1989;78:424–430.
Simon PL, West GA, Rachmilewitz D, Fiocchi C: Investigation of interleukin 1 (IL 1) activity in the intestinal mucosa of Crohn's disease (CD) and ulcerative colitis (UC) patients (abstract). Gastroenterology 1989;96:473.
Ebert E, Wright SH, Lipshutz WH, Hauptmann SP: T-cell abnormalities in inflammatory bowel disease are mediated by interleukin 2. Clin Immunol Immunopathol 1984;33:232–244.
Ming RH, Atluru D, Spellman CW, Imir T, Goodwin JS, Strickland RG: Pericheral blood mononuclear cell interleukin-2 production, receptor generation and lymphokine-activated cytotoxicity in inflammatory bowel disease. J Clin Immunol 1987;7:59–63.
Mueller C, Knoflach P, Zielinski CC: T-cell activation in Crohn's disease. Increased levels of soluble interleukin-2 receptor in serum and supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology 1990;98:639–646.
Crabtree JE, Juby LD, Heatley RV, Lobo AJ, Bullimore DW, Axon ATR: Soluble interleukin-2 receptor in Crohn's disease: Relation of serum concentrations to disease activity. Gut 1990;31:1033–1036.
Brynskov J, Tvede N: Plasma interleukin-2 and soluble/shed interleukin-2 receptor in serum of patients with Crohn's disease. Effect of cyclosporin. Gut 1990;31:795–799.
Fiocchi C, Hilfiker ML, Youngman KR, Doerder NC, Finke JH: Interleukin 2 activity of human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Gastroenterology 1984;86:734–742.
Kusugami K, Youngman KR, West GA, Fiocchi C: Intestinal immune reactivity to interleukin 2 differs among Crohn's disease, ulcerative colitis and control. Gastroenterology 1989;97:1–9.
Fiocchi C, Tubbs RR, Youngman KR: Human intestinal mucosal mononuclear cells exhibit lymphokine-activated killer cell activity. Gastroenterology 1985;88:625–637.
Hogan PG, Hapel AJ, Doe WF: Lymphokine-activated and natural killer activity in human intestinal mucosa. J Immunol 1985;135:1731–1738.
Strickland RG, Robinson JM, Greenlee LS, McLaren LC: Circulating interferon in active inflammatory bowel disease. Gastroenterology 1980;78:A1271.
Simon MR, Gatmaitan BG, Weinstock JV, Salkeld RM, Williams BB: Antiviral activity in sera of patients with Crohn's disease. Am J Med Sci 1983;286:21–25.
Stalnikowicz R, Goder K, Karmeli F, Fiocchi C, Rachmilewitz D: (2′–5′) Oligoadenylate synthetase activity in leucocytes of patients with inflammatory bowel disease. Gut 1985;26:556–561.
Muller DS, Manger B, Zawatsky R, Kirchner H, Kalden JR: Mitogen-induced γ interferon production in peripheral blood lymphocytes from patients with colorectal tumors. Immunobiology 1984;166:494–499.
Mutchnick MG, Lee HH, Hollander DI, Haynes GD, Chua DC: Defective in vitro gamma interferon production and elevated serum immunore-active thymosin b4 levels in patients with inflammatory bowel disease. Clin Immunol Immunopathol 1988;47:84–92.
Lieberman BY, Fiocchi C, Youngman KR, Sapatnekar WK, Proffitt MR: Interferon γ production by human intestinal mucosal mononuclear cells. Decreased levels in inflammatory bowel disease. Dig Dis Sci 1988;33:1528–1536.
Ouyang Q, El-Youssef M, Yen-Lieberman B, Sapatnekar W, Proffitt MR: Expression of HLA-DR antigens in inflammatory bowel disease mucosa: Role of intestinal lamina propria mononuclear cell-derived interferon γ. Dig Dis Sci 1988;33:1528–1536.
Rachmilewitz D, Stainikowicz R, Karmeli F, Youngman K, Fiocchi C: (2′–5′) Oligoadenylate synthetase activity in intestinal mononuclear and epithelial cells of inflammatory bowel disease patients. Scand J Gastroenterol 1988;23:941–947.
Targan S, Britvan L, Kendal R, Vimadalal S, Soll A: Isolation of spontaneous and interferon inducible natural killer cells from human colonic mucosa: Lysis of lymphoid and autologous epithelial target cells. Clin Exp Immunol 1983;54:14–22.
MacDermott RP, Bragdon MJ, Kodner IJ, Bertovich MJ: Deficient cell-mediated cytotoxicity and hyporesponsiveness to interferon and mitogen lectin by inflammatory bowel disease peripheral blood and intestinal mononuclear cells Gastroenterology 1986;90:6–11.
Deem RL, Shanahan F, Targan SR: Triggered human mucosal T cells release tumour necrosis factor-alpha and interferon-gamma which kill human colonic epithelial cells. Clin Exp Immunol 1991;83:79–84.
Eliakim R, Karmeli F, Razin E, Rachmilewitz D: Role of platélet-activating factor in ulcerative colitis. Gastroenterology 1988;95:1167–1172.
Mahida YR, Kurlak L, Gallagher A, Hawkey CJ: Circulating and tissue interleukin 6 (IL 6) levels in inflammatory bowel disease (abstract). Gastroenterology 1990;98:461.
Suzuki Y, Saito H, Kasanuki J, Kishimoto T, Tamura Y, Yoshida S: Significant increase of interleukin 6 production in blood mononuclear leukocytes obtained from patients with active inflammatory bowel disease. Proc 6th Int Congr Mucosal Immunol, 1990, abstract No. 237.
Murata Y: Alterations of immunoglobulin secretion, and interleukin-2 (IL-2) and IL-6 production by peripheral blood mononuclear cells from patients with ulcerative colitis. Proc 6th Int Congr Mucosal Immunol, 1990, abstract No. 268.
Stevens C, Walz G, Zanker B, Singaram C, Lipman M, Strom TB: Interleukin-6 (IL-6), interleukin-1 beta (IL-1b) and tumor necrosis factor alpha (TNFα) expression in inflammatory bowel disease (IBD) (abstract). Gastroenterology 1990;98:475.
Isaacs K, Sartor RB, Wang A, Haskill JS: Profiles of cytokine activation in inflammatory bowel disease: Measurement by cDNA amplification (abstract). Gastroenterology 1990;98:455.
Yagita A, Orima I: The etiology of Crohn's disease and TNF. Proc 6th Int Congr Mucosal Immunol, 1990, abstract No. 238.
Maeda M, Watanabe N, Yamauchi N, Himeno T, Tsuji Y, Okamoto T, Niitsu Y: Significance of TNF in inflammatory bowel disease. Proc 6th Int Congr Mucosal Immunol, 1990, abstract No. 422.
Mahida YR, Wu K, Lamming CED, Jewell DP, Hawkey CJ: Human colonic tumour necrosis factor-α (TNFα) production (abstract). Gastroenterology 1989;96:313.
Pullman W, Hapel AJ, Doe WF: Colony stimulating factor production by intestinal lamina propria cells is increased in inflammatory bowel disease (abstract). Gastroenterology 1988;94:361.
Fiocchi C, Levine AD, West GA, Youngman KR, Matsuura T: Differential inhibitory effect of IL4 on IL2-induced cytotoxicity by intestinal lamina propria mononuclear cells (LPMC) in inflammatory bowel disease (IBD) (abstract). Gastroenterology 1990;98:448.
Rossiter G, Podolsky DK: Expression of transforming growth factor alpha and beta in colonic mucosa in ulcerative colitis (abstract). Gastroenterology 1990;98:471.
Graham MF, Bryson GR, Diegelmann RF: Transforming growth factor b1 selectively augments collagen synthesis by human intestinal smooth muscle cells. Gastroenterology 1990;99:447–453.
Paul WE: Pleiotropy and redundancy: T cell-derived lymphokines in the immune response. Cell 1989;57:521–524.
Max JL: Cytokines are two edged swords in disease. Science 1988;239:257–258.
Neta R, Oppenheim JJ: Why should internists be interested in interleukin-1? Ann Intern Med 1988; 109:1–3.
Bendtzen K: Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol Lett 1988;19:183–192.
Waage A, Brandtzaeg P, Halstensen A, Kierluf P, Espevik T: The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. J Exp Med 1989;169:333–338.
Barnes PF, Fong S-J, Brennan PJ, Twomey PE, Mazumder A, Modlin RL: Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J Immunol 1990;145:149–154.
Horii Y, Muraguchi A, Iwano M, Matsuda T, Hirayama T, Yamada H, Fujii Y, Dohi K, Ishikawa H, Ohmoto Y, Yoshisaki K, Hirano T, Kishimoto T: Involvement of IL-6 in mesangial proliferative glomerulonephritis. J Immunol 1989; 143:3949–3955.
Bhardwaj N, Santhanam U, Lau LL, Tatter SB, Ghrayeb J, Rivelis M, Steinman RM, Seghal PB, May LT: IL-6/IFN-β2 in synovial effusions of patients with rheumatoid arthritis and other arthritides. Identification of several isoforms and studies of cellular sources. J Immunol 1989;143: 2153–2159.
Khalil N, Bereznay O, Sporn M, Greenberg AH: Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J Exp Med 1989;170:727–737.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Fiocchi, C. Production of inflammatory cytokines in the intestinal lamina propria. Immunol Res 10, 239–246 (1991). https://doi.org/10.1007/BF02919699
Issue Date:
DOI: https://doi.org/10.1007/BF02919699